Medicine Recommendations

Treatment of house dust mite sensitisation

Primary prevention of breast cancer in postmenopausal women at moderate or high risk

Hormonal treatment for early breast cancer (NICE TA112)

NICE TA112 - Hormonal therapies for the adjuvant treatment of early oestrogen-receptor-positive breast cancer 

For treatment of Myasthenia Gravis

Methotrexate induced mucosistis or myelosuppression

treatment of adult male patients with advanced hormonedependent prostate cancer - patients without spinal metastases

Degarelix for treating advanced hormone-dependent prostate cancer (NICE TA404)

Breast cancer

NICE guideline NG101: Early and locally advanced breast cancer: diagnosis and management

Treatment of essential thrombocythemia or polycythaemia vera with a high risk for thromboembolic complications

Psoriasis

The prevention of recurrent painful vaso-occlusive crises including acute chest syndrome in adults suffering from symptomatic Sickle Cell Syndrome

Treatment of chemotherapy induced colitis

Unlicensed use in non-acute treatment of recurrent gastrointestinal bleeding disorders (including angiodysplasia, small bowel dysplasia, gastric antral vascular ectasia, haemorrhagic telangiectasia)

Unlicensed use for orthostatic intolerance disorders e.g. postural orthostatic tachycardia syndrome (PoTS)

Unlicensed use in Secretory Gastrointestinal Disorders (e.g. enterocutaneous fistula, high output stoma and refractory diarrhoea)

Breast cancer

NICE guideline NG101: Early and locally advanced breast cancer: diagnosis and management

Unlicensed use in non-acute treatment of recurrent gastrointestinal bleeding disorders (including angiodysplasia, small bowel dysplasia, gastric antral vascular ectasia, haemorrhagic telangiectasia)

Unlicensed use for orthostatic intolerance disorders e.g. postural orthostatic tachycardia syndrome (PoTS)

Unlicensed use in Secretory Gastrointestinal Disorders (e.g. enterocutaneous fistula, high output stoma and refractory diarrhoea)

Autoimmune haemolytic anaemia